Machine Learning Signature Links Cell Cycle Crosstalk to Aggressive Prostate Cancer Risk
An automated machine learning signature tracking E2F and G2/M pathway crosstalk stratifies aggressive prostate cancer risk and uncovers selective vulnerabilities ...




